Current Status of the Diagnosis and Management of Osteoporosis
Open accessThe DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Abstract
Osteoporosis has been defined as the silent disease of the 21st century, becoming a public health risk due to its severity, chronicity and progression and affecting mainly postmenopausal women and older adults. Osteoporosis is characterized by an imbalance between bone resorption and bone production. It is diagnosed through different methods such as bone densitometry and dual X-rays. The treatment of this pathology focuses on different aspects. On the one hand, pharmacological treatments are characterized by the use of anti-resorptive drugs, as well as emerging regenerative medicine treatments such as cell therapies and the use of bioactive hydrogels. On the other hand, non-pharmacological treatments are associated with lifestyle habits that should be incorporated, such as physical activity, diet and the cessation of harmful habits such as a high consumption of alcohol or smoking. This review seeks to provide an overview of the theoretical basis in relation to bone biology, the existing methods for diagnosis and the treatments of osteoporosis, including the development of new strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Thus, it is thought that imbalances in these molecular and cellular processes alter bone homeostasis, driving the pathophysiology of osteoporosis [5,6].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“In addition to bone densitometry, general blood and urine tests can provide important information about an individual’s overall health and any underlying conditions that may be contributing to osteoporosis.”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“This classification is widely accepted as a diagnostic criterion, with sensitivity and specificity close to 90% [6].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149 · cited 1×
“The primary purpose of a pharmacological treatment is to reduce the risk of fractures and to improve the quality of life of people with osteoporosis [90].”
BackgroundEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
Hernlund, E., Svedbom, A., Ivergård, M., Compston, J., Cooper, C., Stenmark, J., McCloskey, E. V., Jönsson, B., & Kanis, J. A. (2013) · Archives of Osteoporosis · doi:10.1007/s11657-013-0136-1 · Cited by 2,675 · cited 6×
“In 1993, the WHO defined osteoporosis as a systemic skeletal disease characterized by low bone mass, the deterioration of the microarchitecture of bone tissue, a consequent increase in bone fragility and a susceptibility to fractures [1].”
MethodInfluentialCompston, J. E., McClung, M. R., & Leslie, W. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32112-3 · Cited by 2,449
An overview and management of osteoporosis
Sözen, T., Özışık, L., & Çalık Başaran, N. (2019) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2016.048 · Cited by 2,262 · cited 3×
“Individuals with uncomplicated osteoporosis may remain asymptomatic until a fracture occurs [5].”
BackgroundDiagnosis of osteoporosis and assessment of fracture risk
Kanis, J. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08761-5 · Cited by 2,260 · cited 1×
“5–2; and (v) severe osteoporosis value: the risk is similar to that of established osteoporosis [89].”
BackgroundStroke risk factors, genetics, and prevention
Boehme, A. K., Esenwa, C., & Elkind, M. S. V. (2017) · Circulation Research · doi:10.1161/circresaha.116.308398 · Cited by 1,952 · cited 1×
“It is another clear cause of bone density loss, not only because of the drop in hormone levels but also because, histologically, there is a decrease in the average thickness of the bone wall, but bone resorption remains high with aging [34].”
BackgroundEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900 · cited 1×
“race, since Caucasians and Asians are at a greater risk than Blacks and Polynesians [32]; sex, since it has been found that the risk is greater in women than in men [33]; and age, since each decade increases the risk by 1.”
BackgroundHorwitz, E. M., Prockop, D. J., Fitzpatrick, L. A., Koo, W. W. K., Gordon, P. L., Neel, M., Sussman, M., Orchard, P., Marx, J. C., Pyeritz, R. E., et al. (1999) · Nature Medicine · doi:10.1038/6529 · Cited by 1,824 · cited 1×
“Decades ago, clinical studies were already conducted in children, using bone marrow MSCs (BM-MSCs) for the treatment of severe osteogenesis imperfecta [140].”
Background
Research works printed but not linked: 2
- 31. Quevedo L.I. Martínez B.M. Castillo N.M. Rivera F.N. [Vitamin D receptor gene polymorphisms and risk of hip fracture in Chilean elderly women] Rev. Med. Chile 2008 136 475 481 18769790
- 107. Società Italiana Dell’osteoporosi del Metabolismo Minerale e delle Malattie dello Scheletro Clinical Cases in Mineral and Bone Metabolism: The Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases CIC Edizioni Internazionali Rome, Italy 2004
Cited by
Items 201–300 of 473
Chang, Q., Zhang, M., Yu, Q., Yu, S.-R., Tang, Y., Pan, G., Cheng, Y., Qin, J., Wang, X., & Xia, Y. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118000 · Cited by 3
Mechanisms of bone regeneration repair and potential and efficacy of small molecule drugs
Zhang, K., Li, H., Wang, T., Li, F., Xie, Z., Luo, H. W., Zhu, X., Kang, P., Kang, Q., Fei, Z., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118070 · Cited by 7
Həsənova, N. A., Əzizova, G. İ., İslamzadə, F. İ., Şahverdiyeva, İ. C., & Həsənzadə, N. Ç. (2025) · Azerbajdžanskij medicinskij žurnal · doi:10.34921/amj.2025.3.02 · Cited by 3
Khurmah, M. H. A., Alkhatatbeh, M. J., Alshogran, O. Y., & Alarda, H. M. (2024) · Public Health Nursing · doi:10.1111/phn.13379 · Cited by 4
Shen, E., Piao, M., Li, Y., Wu, Y., Li, S., Lee, S. H., Jin, L., & Lee, K. Y. (2024) · Cells · doi:10.3390/cells13161352 · Cited by 3
“To date, therapeutic options remain limited [15–17].”
Antonescu, O. R., Silişteanu, S. C., Venter, A. C., Racheriu, M., Antonescu, I. E., & Nemes-Nagy, E. (2024) · Balneo and PRM Research Journal · doi:10.12680/balneo.2024.756 · Cited by 4
Novel MRI semiquantitative scores for vertebral fat-water assessment in aging and spinal disorders
Din, R. U., & Yang, H. (2025) · Chinese Journal of Academic Radiology · doi:10.1007/s42058-025-00182-3 · Cited by 4
“Worldwide, elderly population is increasing while osteoporosis will be one of the major healthcare challenges in the future [ 10].”
Suttho, D., Apibantaweesakul, S., Soponputthaporn, J., Hemapaibun, S., Santipongphibool, M., & Tengcharoenkul, C. (2024) · Journal of Bone Metabolism · doi:10.11005/jbm.24.791 · Cited by 3
Ekeuku, S. O., Zarir, S. Z., Razali, A. N., Zaidi, S. M., Jinnah, N. H. M. A., Muhamad, M. L. N., Wong, S. K., & Chin, K. (2025) · Biomedicines · doi:10.3390/biomedicines13051220 · Cited by 2
“Osteoporosis, marked by a decline in bone mass and structural integrity, is a major cause of skeletal fragility and fractures [1].”
Li, H., & He, J. (2025) · Medicine · doi:10.1097/md.0000000000045532 · Cited by 4
“[1,2] According to the World Health Organization, osteoporosis is diagnosed when bone mineral density (BMD) is 2.5 standard deviations or more below the average value of young healthy adults.”
InfluentialChowdhury, A., Druvo, M. M. R., Islam, M. S., Uddin, K. M. M., & Uddin, M. A. (2025) · Clinical eHealth · doi:10.1016/j.ceh.2025.10.003 · Cited by 2
Tailoring human joint-on-a-chip: from biological principles, materials, to disease modeling
Wang, X., Ong, L. J. Y., Karperien, M., & Wen, C. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102549 · Cited by 2
Merlan, C., Buda, S., Oancea, A., Jianu, N., Onea, T. N., Tot, B., Udrescu, L., Groza, V., Udrescu, M., Lombrea, A., et al. (2025) · Nutrients · doi:10.3390/nu17233759 · Cited by 2
“Depending on its etiology, osteoporosis can be divided into primary or secondary [4].”
Osteoporosis: definition, diagnosis, and considerations prior to starting treatment
Vidal, M., & Lane, N. E. (2026) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2026.101456 · Cited by 2
Does Drug Type Influence Surgical Outcome in MRONJ? A Comparison of Denosumab and Zoledronate
Park, J. H., Choi, S. Y., Son, A., Hwang, S.-W., Kim, J.-W., & Kim, S. (2026) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2026.01.003 · Cited by 2
Huang, J., Lin, M., Deng, K., & Zhou, S. (2026) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-025-01147-7 · Cited by 2
Cevallos, A., Tarragó, A., & Rissech, C. (2026) · American Journal of Biological Anthropology · doi:10.1002/ajpa.70241 · Cited by 2
Deng, J., Su, S., & Tian, L. (2026) · Archives of Osteoporosis · doi:10.1007/s11657-026-01697-7 · Cited by 2
Puspita, R. M., Agustiningsih, D., & Purwanti, N. (2026) · Physiology International · doi:10.1556/2060.2026.00710 · Cited by 2
Li, C., Zhang, X., Tang, P., Li, M., Hu, W., Zhou, M., & Xu, J. (2026) · Cells · doi:10.3390/cells15100935 · Cited by 2
“Despite considerable advances in diagnostic approaches and fracture-risk assessment, fracture prevention remains the central objective of treatment, with antiresorptive agents serving as the therapeutic mainstay and anabolic drugs providing added benefit in selected high-risk patients [8].”
Wang, Z., Lin, H., Li, Y., Li, Y., Xu, C., & Gan, Y. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04588-8 · Cited by 2
“Although these interventions are effective in reducing fracture risk and improving bone mineral density, their long-term clinical use is often limited by safety concerns, high costs, and variable patient adherence [21].”
Amyotrophic lateral sclerosis and osteoporosis: a two-sample Mendelian randomization study
Li, J., Ma, C., Huang, H., & Liao, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1305040 · Cited by 2
Li, J., Wang, T., Ma, L., Zhang, Y., & Zhu, D. (2024) · World Journal of Stem Cells · doi:10.4252/wjsc.v16.i2.151 · Cited by 2
Lu, Y., Wang, W., Yang, B., Cao, G., Du, Y., & Liu, J. (2024) · Indian Journal of Orthopaedics · doi:10.1007/s43465-024-01152-0 · Cited by 2
“This study aimed to investigate the pathogenesis of OP, a degenerative systemic bone metabolic disease characterized by reduced bone mass, bone resorption, and microstructural deterioration leading to fractures and impacting health [11, 12].”
Wang, Z., Fang, Z., & Xie, X.-L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1402937 · Cited by 3
Structural equation model analysis of the effect of visceral fat on osteoporosis
Tong, M., Li, Y., Rong, K., Sun, Q., Dai, J., & Huang, Y. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-04888-5 · Cited by 2
Wen, R., Huang, R., Xu, K., & Yi, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141807 · Cited by 2
Zhu, M., Xu, M.-Z., Li, C., Wang, J., Li, C., Gong, Y.-Q., Jin, J., Lü, K., & Hao, Y.-M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1564957 · Cited by 2
“…that can occur even with normal BMD T-scores and in the absence of other metabolic bone diseases; a diagnosis of OP can be confirmed with a T-score of ≤ − 2.5, without visible fractures, at specific sites including the femoral neck, lumbar spine, distal third of the forearm, and total hip (21).”
InfluentialmiR-127-3p regulates osteoporosis progression by targeting VAMP2 to modulate cell differentiation
Chen, J., Lei, J., Wang, G., Qin, H., & Li, Y. (2025) · Journal of Endocrinology · doi:10.1530/joe-25-0032 · Cited by 2
Tang, H., Zhao, J., Yan, X., Zheng, Z.-Y., Bai, W., Tang, Z., & Liu, X. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s529217 · Cited by 2
“9 RA is an autoimmune disease characterized by synovitis, cartilage damage, and bone erosion in peripheral joints.”
Jiba, U., Adil, M., Rafiya, K., Hasan, N., Ahmad, F. J., & Amin, S. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107470 · Cited by 2
Xiong, K., Li, J., Liu, Y., Pan, Y., Huang, Y., Zhang, L., Zhang, L., Tang, M., Li, J., & Sun, H. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10783-0 · Cited by 2
Xiang, L., Xu, R., Ren, X., Li, Z., Xiang, S., & Wu, X. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003161 · Cited by 2
“Our findings regarding the protective role (regardless of intensity or types) of physical activity against osteoporosis align with previous studies [ 17 , 18 ] .”
Carşote, M., Stanciu, M., Popa, F. L., Sima, O.-C., Caraban, B. M., Dumitrascu, A. S., Iliescu, M. G., & Nistor, C. E. (2023) · Balneo and PRM Research Journal · doi:10.12680/balneo.2023.637 · Cited by 2
“In case of no response to vitamin D supplementation and intravenous bisphosphonates, as, for instance, suppression of bone turnover markers, a bone biopsy should be advised [54].”
BackgroundAn Overview of Research in the Field of Elderly Health: Bibliometric Analysis
Nal, M., & Nal, B. (2024) · Geriatrik Bilimler Dergisi · doi:10.47141/geriatrik.1382709 · Cited by 3
Recent Progress on the Skeletal Research of Tocotrienol
Chin, K. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-55489-6_8 · Cited by 1
Risk Factors for Decreased Bone Density in Adults with Celiac Disease
Niknam, R., Nowrouzi, K., Mahmoudi, L., Motazedian, N., Ejtehadi, F., Boogar, S. S., & Zamani, A. (2024) · Shiraz E-Medical Journal · doi:10.5812/semj-143039 · Cited by 1
Identification of Risk Factors for Primary Osteoporosis: The Role of Cervical Ligament Ossification
Wang, D., Yang, J., Li, H., Chen, Y., Lin, W., Lei, S., You, Y., Liu, C., Lin, Y., Guo, H., et al. (2024) · Medical Science Monitor · doi:10.12659/msm.944963 · Cited by 1
Zhang, Z., Hu, T., Wang, Y., Zhu, X., Liu, Y. M., Gao, L., Zhang, Z., Gao, E., Zhang, W., & Zheng, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-71229-1 · Cited by 1
Stecchi, M., Rossi, A., Santoni, M., Bandini, F., & Brodosi, L. (2024) · Nutrients · doi:10.3390/nu16193348 · Cited by 1
“…factors for these diseases, lifestyle plays a critical role in prevention while also being crucial in their treatment in the general population [17,18]; in particular, the Mediterranean diet (MedDiet) remains a dietary model that promotes healthy aging, reduces the incidence of the most common…”
BackgroundResultA Histo-Physiological Study of The Effect of Resveratrol on Osteoporosis-Induced in Rats
Ali, M. W., & Abdulazeez, Z. M. (2024) · South Eastern European Journal of Public Health · doi:10.70135/seejph.vi.951 · Cited by 1
“The complex and varied etiology of OP is influenced by interactions between endocrine, nutritional, genetic, physiological, and immunological factors [4].”
BackgroundFang, Z., Zhao, J., Zhang, Y., Hua, X., Li, J., & Zhang, X. (2024) · Cureus · doi:10.7759/cureus.71734 · Cited by 2
Osteoporosis y riesgo de fracturas en mujeres posmenopáusicas. Revisión bibliográfica
Diaz, O. M. F., Ortega, M. C. S., & Gonzabay, B. M. A. (2025) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v8i6.15647 · Cited by 1
Effects of ADRM1 on osteoblast differentiation and mineralization in osteoporosis.
Zhuang, H., Lin, Y., Lin, C., Zheng, M., Yao, X., & Xu, Y.-J. (2025) · American journal of translational research · doi:10.62347/xsov4523 · Cited by 1
“However, these treatments do not significantly enhance the microstructural integrity of trabecular bones [3].”
Optimizing PSO for classification: comparison of Naïve Bayes and C4.5 for osteoporosis prediction
Anugerahwati, Z., & Lestari, S. B. (2025) · SINERGI · doi:10.22441/sinergi.2025.2.011 · Cited by 1
Wang, B., Fan, Y., Tang, S., Guo, W., Li, Y., & Dai, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1578954 · Cited by 2
Li, Y., Yue, Y., Cen, C., & Liu, B. (2025) · Human Cell · doi:10.1007/s13577-025-01273-0 · Cited by 1
Chang, H., Han, W., Li, J., Jiao, D., Liu, F., Gao, T., Zhu, W., & Gong, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1613065 · Cited by 1
He, D., Di, J., Jiang, P., Liu, L., Wang, F., & Xiang, C. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70612 · Cited by 1
Chen, Z., Leng, C., Rui, T., Feng, C., Li, T., Yu, Y., Zhong, L., & Fan, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1619687 · Cited by 1
Iqbal, S., Abuajlan, M., Alktheri, A., Malik, Z. I., Ahmad, A. M. R., Qudah, T., & AbuMweis, S. S. (2025) · Archives of Osteoporosis · doi:10.1007/s11657-025-01611-7 · Cited by 1
“For postmenopausal women, osteoporosis results from a decline in estrogen levels, which directly influences osteo-clastogenesis and inhibits osteoblast activity, leading to accelerated bone turnover [1].”
Li, Y., Xie, X., Liu, Y., Sun, H., Gong, Z., & Ding, W. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1649964 · Cited by 2
Mykhailovska, N. S., Stetsiuk, І. O., Manuilov, S. M., Mykhailovskyi, Y. М., Lisova, O. O., & Шершньова, О. В. (2025) · Pathologia · doi:10.14739/2310-1237.2025.2.332421 · Cited by 1
Saini, J. S., Kaushik, N., Jain, P., Kumar, J., & Singh, B. (2025) · Cureus · doi:10.7759/cureus.95580 · Cited by 1
“…modalities often compare favorably to or even exceed the traditional methods in terms of safety and patient satisfaction but are always limited by cost, special training, and infrastructure demands-factors that can restrict implementation outside of the more resource-endowed facilities [22].”
InfluentialZhang, Y., 陈, 冠., & Jing, Y. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100413 · Cited by 1
Xie, T., Ye, G., Chen, Y., Fan, S., Li, G., Wang, X., Xu, C., Chen, Z., & Hong, J. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112945 · Cited by 1
Wu, N., Zhang, L., & Guo, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1682548 · Cited by 1
Dai, C., Wang, N., Zhang, Y., Wu, G., Zhang, Y., & Dong, Y. (2025) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s552958 · Cited by 1
Huang, H., Yu, J., LI, X., Ling, M., Zhang, C., & Fan, Y. (2025) · International Journal of Clinical Practice · doi:10.1155/ijcp/6662987 · Cited by 1
The association between glutathione reductase and postmenopausal osteoporosis: a retrospective study
Wang, J., Wu, K., Chen, M., Li, X., Ban, S., Li, B., He, K., Yang, H., Dai, Q., Guo, S., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1679509 · Cited by 1
Vitamin K2 as a Bone Protective Bioactive Against Osteoporosis and Fragility Fracture
Chin, K. Y. (2026) · Advances in biochemistry in health and disease · doi:10.1007/978-3-032-14441-6_16 · Cited by 1
Liu, Y., Zheng, Y., Lan, J. X., Huang, Q., Chen, J., Long, Y., Zhou, X., Zhou, T., Xiang, G., & Lou, J. C. (2026) · Molecules · doi:10.3390/molecules31050867 · Cited by 1
“These natural changes can manifest as reduced bone mineral density, altered bone turnover coupling [70], impaired mobility [71], and height loss [72].”
Guo-xu, Z., Qian, Z., Li, X., & Yu, B. (2026) · Medicine · doi:10.1097/md.0000000000048040 · Cited by 1
“[4] The disease causes an estimated 1.5 million fractures annually in the United States, [4,9] resulting in higher risks of fractures and death, greater medical expenditures, and a substantial deterioration in quality of life.”
InfluentialWang, Y., Goh, L. L., & Chin, K. (2026) · Biomolecules and Biomedicine · doi:10.17305/bb.2026.13914 · Cited by 1
“Anti-resorptive agents, including bispho-sphonates, denosumab, and selective estrogen receptor modulators, inhibit osteoclast-mediated bone resorption, while anabolic treatments, such as romosozumab and teriparatide, focus on stimulating osteoblastic bone formation [9].”
InfluentialBone health in patients with isolated methylmalonic acidemia
Elsayed, S. M., Elsedfy, H. H., Omar, O. H., Elnabi, M. H., Mohamed, M. E., & Abdel-Fattah, N. H. (2026) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-026-00853-5 · Cited by 1
“It can be prevented, diagnosed, and treated before complications occur, and therefore, early detection in vulnerable populations should be mandatory [16].”
Peng, X., Zheng, X., Li, X., Pang, X., Jin, J., Liu, H., Zhang, H., & Xie, Y. (2026) · Foods · doi:10.3390/foods15081349 · Cited by 1
“This condition is characterized by reduced bone mass and density, microarchitectural deterioration, increased skeletal fragility, and a heightened risk of fractures [2].”
Huang, Y., Zhou, R., Liang, R., & Shen, J. (2026) · Bone · doi:10.1016/j.bone.2026.117911 · Cited by 2
Calabriso, N., Massaro, M., Quarta, S., Siculella, L., Santarpino, G., Verri, T., Gerardi, C., Giovinazzo, G., & Carluccio, M. A. (2026) · Biology · doi:10.3390/biology15090719 · Cited by 1
Li, S., Hu, Y., Ding, S., Fang, J., & Liu, G. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c01315 · Cited by 1
Yi, W., Xu, W., Yang, T., Lyu, X., Wang, Z., Chen, L., Zhang, J., Zhong, Y., Wang, S., & Wu, B. (2026) · Inflammation Research · doi:10.1007/s00011-026-02259-w · Cited by 1
“The disease is caused by an imbalance between bone resorption and bone formation, with bone mineral density assessments and dual-energy X-ray absorptiometry (DXA) being the primary tools for fracture risk evaluation [4].”
Jiang, H., Ma, L., Liu, Y., Li, M., Sun, J., & Ma, J. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-026-10846-8 · Cited by 1
“Its core pathological mechanism involves an imbalance between weakened osteoblastic bone formation and enhanced osteoclastic bone resorption (Aibar-Almazan et al. 2022).”
Russo, M., Conza, G., Lepre, C. C., Martin, G., Itro, A., Braile, A., Grossi, G., Tangredi, N., D’Amico, M., Hermenean, A. O., et al. (2026) · Cells · doi:10.3390/cells15121119 · Cited by 1
“However, despite the effectiveness of multidisciplinary care models in reducing the risk of secondary fractures [12–15], diagnosing OP remains a clinical challenge, as the disease often progresses without clear symptoms, typically being diagnosed only after a fragility fracture has occurred.”
Zhang, Y., Wu, G., Hou, J., Liu, Q., Guo, Z., Zhang, Y., & Li, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1815222 · Cited by 1
Chronic Δ9-Tetrahydrocannabinol Inhalation Following Osteoporosis Results in Bone Deficits
Powell, A., Clouse, G., Penman, S. L., Taylor, I. T., Sadar, F., Ehan, N., Varma, A., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2026) · Biomedicines · doi:10.3390/biomedicines14071620 · Cited by 1
“Osteoporosis, one of the most common metabolic bone diseases, is characterized by low bone mineral density and an elevated risk of fractures [1].”
Factors influencing anti-osteoporotic medicine consumption in Uzbekistan: A descriptive analysis
Yusupova, Z., & Saipova, D. (2026) · Journal of Applied Pharmaceutical Research · doi:10.69857/joapr.v14i4.2090 · Cited by 1
Efectos del Hilit sobre el riesgo de caída y las habilidades funcionales en el adulto mayor
Gonzalez-Murillo, R., Afanador-Restrepo, D. F., & García-Garro, P. A. (2022) · Revista Sapientía · doi:10.54278/sapientia.v14i28.124 · Cited by 1
Self-citationIran osteoporosis registry: protocol for nationwide study
Sanjari, M., Fahimfar, N., Mansourzadeh, M. J., Khalagi, K., Hesari, E., Hajivalizadeh, F., Namazi, N., Sajjadi‐Jazi, S. M., Mahmoudi, M., Tanhaei, M., et al. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01334-x · Cited by 1
Animal Models for the Study of Osteoporosis
Abdi, S. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815196382124010014 · Cited by 2
Zhong, W., Zhao, A., Wei, X., Mao, S., Li, P., Shen, Q., Zhang, H., Jiang, H., Wang, P., & Zhang, Y. (2024) · Nutrients · doi:10.3390/nu16070973 · Cited by 1
“As osteoporosis [5] and constipation [6] affect middle-aged and elderly people as well, the consumption of OPO may have a similar health-promoting effect on them.”
BackgroundThe relationship between menopause and bone health
Bjelica, A. (2024) · Galenika Medical Journal · doi:10.5937/galmed2409072b · Cited by 1
Diagnosis and treatment of osteoporosis: a paradigm shift
Геннадьевна, Л. К., & Омариевна, У. Ф. (2024) · FOCUS Endocrinology · doi:10.15829/2713-0177-2024-5-1-09 · Cited by 1
Chen, J., Hu, L., Li, N., Deng, W., Xu, X., Wang, L., Zhao, K., Lu, S., Liu, X., Cheng, X., et al. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00841-9 · Cited by 1
“As a serious, progressive and early asymptomatic, it will lead to disability and increased risk of fracture [4].”
BackgroundDou, S., Fang, W., Wang, W., & Wang, H. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s506960 · Cited by 1
Osteoporosis: causas, riesgos y prevención
Zapata-Ortega, R. N., & Gasca-García, A. G. (2025) · Atención Familiar · doi:10.22201/fm.14058871p.2025.2.91032 · Cited by 1
Chen, Y., Zhang, Y., Zheng, Q., & Sun, L. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-087480 · Cited by 1
Wang, M., Guo, B., Liu, X., Cao, Q., & He, J. (2025) · Chemical Papers · doi:10.1007/s11696-025-04128-y · Cited by 1
Wang, P., Xu, Z., Wang, X., Cui, H., Wang, Z., & Liu, Y. C. (2023) · Research Square · doi:10.21203/rs.3.rs-3214593/v1 · Cited by 1
Li, S., Lv, D., Yang, H., Yan, S., Wu, L., & Jia, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1574819/v1
RetractedLi, S., Lv, D., Yang, H., Yan, S., Wu, L., & Jia, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1574819/v2
RetractedLi, S., Lv, D., Yang, H., Yan, S., Jia, Y., & Wu, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1574819/v3
RetractedDepressive Symptoms as Potential Mediator between Physical Activity and Bone Health—A Scoping Review
Houtenbos, S. P., Kuehl, L. K., Wuertz‐Kozak, K., & Wippert, P. (2022) · Osteology · doi:10.3390/osteology2040020
“, ultrasound), for which BMD measurement remains the gold standard [77].”
BackgroundRelación de la artritis reumatoide y osteoporosis
Aguinsaca, K. F. P., Paladines, A. D. C. C., Torres, J. M. C., Garzón, A. J. R., & Rogel, F. A. U. (2023) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v7i1.4635
ao, Y., Chunhui, L., Yao, L., La, Z., Zhaolei, J., Ma, J., & Zhuorui, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2897159/v1
(2023) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2023.05(07).06
An, N., Guo, S., Lin, J., Zhuang, H., Li, J., Meng, H., Su, N. Y., Yang, Y., & Qi, F. (2023) · Research Square · doi:10.21203/rs.3.rs-3288926/v1
Önder, Ç. E., & Yılmaz, N. (2023) · Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi · doi:10.20492/aeahtd.1328824
Yılmaz, R., & Bağçacı, S. (2023) · Medical Bulletin of Haseki · doi:10.4274/haseki.galenos.2023.9388
“Teriparatide, a recombinant human parathyroid hormone [PTH (1-34)], is the first and only available anabolic agent used for treating postmenopausal osteoporosis, male osteoporosis, and steroid-induced osteoporosis in Turkey (3,5,6).”
Lin, X., Shang, L., Shen, S., Wang, Q., Fu, X., & Zhao, G. (2023) · PubMed Central · doi:10.7507/1002-1892.202306071
Designing and implementing a portable ultrasound bone densitometer
Massoud, S., Ruqiah, M., Ismaiel, E., Ahmad, A. S., & Motawej, F. (2023) · Baghdad Science Journal · doi:10.21123/bsj.2023.8539
Peacock-Johnson, A., & Keresztes, P. A. (2023) · Nursing · doi:10.1097/01.nurse.0000991592.29755.37
Metadata
- Authors
- Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. D. C., & López-Ruiz, E.
- Affiliations
- Department of Health Sciences, Campus de Las Lagunillas SN, University of Jaén, E-23071 Jaén, Spain
- Universidad de Granada (ES)
- Fundación Universitaria del Área Andina (CO)
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-08-21
- Volume
- 23
- Issue
- 16
- Pages
- 9465
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9408932
- OpenAlex
- W4293030541
- Cited by
- 412
- References
- 229
- Citations by year
- 2026: 79 · 2025: 156 · 2024: 128 · 2023: 43 · 2022: 6
- FWCI
- 18.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- 2014–2020 Operational Programme FEDER in Andalusia (FMM-AP17196-2019)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- osteoporosis, osteoporosis diagnosis, bone densitometry, dual-energy X-ray absorptiometry, anti-resorptive drugs, regenerative medicine, cell therapy, bioactive hydrogels, non-pharmacological treatment, physical activity, diet, smoking, alcohol consumption, bone resorption, bone biology, postmenopausal women, older adults
- MeSH terms
- Aged, Bone Resorption, Female, Humans, Osteoporosis, Smoking, Health Behavior, Exercise, Bone Density, Osteoporosis, Postmenopausal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.